Cell proliferation and tumour promotion by ethinyl estradiol in rat hepatocarcinogenesis
- PMID: 2044195
- DOI: 10.1093/carcin/12.6.1133
Cell proliferation and tumour promotion by ethinyl estradiol in rat hepatocarcinogenesis
Abstract
A two-stage model of hepatocarcinogenesis is used to study the effect of exposure time to ethinyl estradiol (EE) on promotion of preneoplastic lesions in rat liver induced by diethylnitrosamine (DEN). Young male and female Sprague-Dawley rats initiated by a single dose of DEN (100 mg/kg) were subjected to different times of EE administration incorporated into the diet at 10 p.p.m. (0.5 mg/kg x day). Animals were killed 1 year after initiation. Whereas macroscopic tumours were rarely seen in animals with short exposure (3 or 4 months) or in only-initiated controls, all the animals under a long period of administration (8 months) showed macroscopic tumours. Morphometric studies on glutathione-S-transferase (GST) positive preneoplastic lesions revealed an increase in the mean size of foci and nodules corresponding to 8 months of treatment, whereas no changes were observed between animals with short exposure and only-initiated controls. No differences were seen in the incidence of these lesions between any of the protocols. In addition to an acute hyperplastic effect on non-initiated liver described earlier, our preliminary results suggest cytotoxicity and an enhancement of the liver cell turnover after several months of continuous EE administration. These results taken together suggest that promotion of hepatocarcinogenesis by EE largely depends on the time of exposure to the compound and that chronic effects on the liver cell turnover may play an important role in its ability to promote hepatocarcinogenesis.
Similar articles
-
Cell proliferation and regulation of negative growth factors in mouse liver foci.Carcinogenesis. 1996 Sep;17(9):1835-40. doi: 10.1093/carcin/17.9.1835. Carcinogenesis. 1996. PMID: 8824503
-
Effects of the lignan, arctiin, on 17-beta ethinyl estradiol promotion of preneoplastic liver cell foci development in rats.Anticancer Res. 1998 Mar-Apr;18(2A):1053-7. Anticancer Res. 1998. PMID: 9615764
-
Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol.Cancer Res. 1984 Sep;44(9):3862-9. Cancer Res. 1984. PMID: 6744303
-
Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis.Toxicol Pathol. 2000 Mar-Apr;28(2):215-25. doi: 10.1177/019262330002800201. Toxicol Pathol. 2000. PMID: 10805139 Review.
-
Apoptosis and multistage carcinogenesis in rat liver.Mutat Res. 1995 Dec;333(1-2):81-7. doi: 10.1016/0027-5107(95)00134-4. Mutat Res. 1995. PMID: 8538639 Review.
Cited by
-
Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2046-2053. doi: 10.1158/1055-9965.EPI-22-0439. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35984984 Free PMC article.
-
Role of a novel CAR-induced gene, TUBA8, in hepatocellular carcinoma cell lines.Cancer Genet. 2011 Jul;204(7):382-91. doi: 10.1016/j.cancergen.2011.05.007. Cancer Genet. 2011. PMID: 21872825 Free PMC article.
-
3,2'-Dimethyl-4-aminobiphenyl-induced gallbladder carcinogenesis and effects of ethinyl estradiol in hamsters.Jpn J Cancer Res. 1992 Dec;83(12):1286-92. doi: 10.1111/j.1349-7006.1992.tb02760.x. Jpn J Cancer Res. 1992. PMID: 1483944 Free PMC article.
-
Decreased Diethylnitrosamine-induced Liver Preneoplastic Lesions by Estradiol-3-benzoate Treatment.Toxicol Res. 2011 Dec;27(4):247-51. doi: 10.5487/TR.2011.27.4.247. Toxicol Res. 2011. PMID: 24278579 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials